On the other hand, NEAT1 inhibits erastin-induced ferroptosis by not only increasing GPX4 and SLC7A11-mediated antioxidative pathways but also decreasing ACSL4-mediated lipid peroxidation, which may confer the resistance to erastin in non-small cell lung cancer (NSCLC) cells [84]. Here, ACSL4 is linked to non-small cell lung carcinoma.